SeaSpine to Participate in Upcoming Investor Conferences

CARLSBAD, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the Company will participate in upcoming virtual investor conferences.


Event:

Stifel 2021 Virtual Healthcare Conference


Format:

Fireside Chat


Date:

Tuesday, November 16, 2021


Time:

2:40 pm ET


Event:

Piper Sandler 33

rd

Annual Virtual Healthcare Conference


Format:

Pre-recorded Fireside Chat


Date:

Available on demand beginning Monday, November 22, 2021


About SeaSpine


SeaSpine (


www.seaspine.com


) is a global medical technology company focused on the design, development, and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions, as well as a market leading surgical navigation system, to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic, and cervical spine. SeaSpine’s orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in orthobiologic sciences, as well as spinal implants, software, and advanced optics product development, allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide through a committed network of increasingly exclusive distribution partners.

Investor Relations Contact

Hunter Cabi

(904) 304-9505



[email protected]



Primary Logo